Literature DB >> 14705497

Safety considerations and safe handling of oral chemotherapy agents.

Elaine Griffin1.   

Abstract

As a class of drugs, chemotherapy agents have two unique features. They have low therapeutic indexes, which places patients at an increased risk for medication errors, and they are considered hazardous drugs, which places patients and nurses at risk for environmental exposure. Policies and procedures for handling and administering oral chemotherapy agents are essential to promoting patients' and nurses' safety. Risk-reduction measures for administering oral chemotherapy in nontraditional healthcare settings, such as the home, require instituting a two-person dose-verification system, educating everyone who will administer and handle these agents, and developing procedures for securely and appropriately storing oral chemotherapy agents. Currently, no standardized guidelines exist for handling oral chemotherapy agents, and institutions must develop their own policies and procedures. This article discusses oral chemotherapy safety considerations, including safe handling of these agents, and offers recommendations for practice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14705497     DOI: 10.1188/03.CJON.S6.25-29

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  10 in total

Review 1.  Interventions to promote adherence with oral agents.

Authors:  Susan M Schneider; Kimberly Hess; Tracy Gosselin
Journal:  Semin Oncol Nurs       Date:  2011-05       Impact factor: 2.315

2.  Role of the nurse in patient education and follow-up of people receiving oral chemotherapy treatment in Turkey.

Authors:  Sultan Kav; Humeyra Bostanci
Journal:  Support Care Cancer       Date:  2006-06-07       Impact factor: 3.603

Review 3.  Improving patient safety in hospitals: Contributions of high-reliability theory and normal accident theory.

Authors:  Michal Tamuz; Michael I Harrison
Journal:  Health Serv Res       Date:  2006-08       Impact factor: 3.402

4.  Oral chemotherapy safety practices at US cancer centres: questionnaire survey.

Authors:  Saul N Weingart; Jonathan Flug; Daniela Brouillard; Laurinda Morway; Ann Partridge; Sylvia Bartel; Lawrence N Shulman; Maureen Connor
Journal:  BMJ       Date:  2007-01-12

5.  Safe handling of oral chemotherapeutic agents in clinical practice: recommendations from an international pharmacy panel.

Authors:  Susan Goodin; Niesha Griffith; Beth Chen; Karen Chuk; Mikael Daouphars; Christian Doreau; Rinku A Patel; Rowena Schwartz; Maria José Tamés; Robert Terkola; Barbara Vadnais; Debbie Wright; Klaus Meier
Journal:  J Oncol Pract       Date:  2011-01       Impact factor: 3.840

Review 6.  Oral antineoplastic agents: how do we care about adherence?

Authors:  Marie Barillet; Virginie Prevost; Florence Joly; Bénédicte Clarisse
Journal:  Br J Clin Pharmacol       Date:  2015-10-28       Impact factor: 4.335

Review 7.  A Concept Analysis of Oral Anticancer Agent Self-management.

Authors:  Madilyn Mason; Marcelline R Harris; Joseph A Greer; Yun Jiang
Journal:  Cancer Nurs       Date:  2022 Mar-Apr 01       Impact factor: 2.592

8.  Adherence to Oral Anticancer Medications: Evolving Interprofessional Roles and Pharmacist Workforce Considerations.

Authors:  Gennaro A Paolella; Andrew D Boyd; Scott M Wirth; Sandra Cuellar; Neeta K Venepalli; Stephanie Y Crawford
Journal:  Pharmacy (Basel)       Date:  2018-03-08

9.  Assessment of medication adherence, medication safety awareness and medication practice among patients with lung cancer: A multicentre cross-sectional study.

Authors:  Ningsheng Wang; Biqi Ren; Haisheng You; Yue Chen; Shuzhi Lin; Shuang Lei; Bianling Feng
Journal:  Health Expect       Date:  2022-01-05       Impact factor: 3.318

10.  ACVIM small animal consensus statement on safe use of cytotoxic chemotherapeutics in veterinary practice.

Authors:  Annette N Smith; Shawna Klahn; Brenda Phillips; Lisa Parshley; Peter Bennett; Andi Flory; Rosemary Calderon
Journal:  J Vet Intern Med       Date:  2018-03-30       Impact factor: 3.333

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.